FDA Drugs recall ·
NAD+ (Nicotinamide adenine dinucleotide) for Injection… recall
This is an FDA Class I recall — the most serious type.
- Recall number
- D-0094-2026
- Date
- (initiated July 30, 2025)
- Company / brand
- GenoGenix LLC
2840 Nw 2nd Ave Ste 204, Boca Raton, FL, United States - Category
- Drugs › Class I
- Classification
- Class I
- Status
- Ongoing
- Hazard tags
- Sterility Microbial contamination
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
Why was it recalled?
Microbial Contamination of Sterile Products: elevated endotoxin levels
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot#: GG121624-023, within expiry
Distribution
US Nationwide.
What does Class I mean?
Class I is the most serious FDA recall class: there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
Source: FDA (drugs), recall D-0094-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.